The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents

Mark H. Ma, Hank H. Yang, Kimberly Parker, Steven Manyak, Jeffrey M. Friedman, Cibby Altamirano, Zhi qun Wu, Mitesh J. Borad, Malka Frantzen, Evanthia Roussos, Jason Neeser, Amy Mikail, Julian Adams, Nelida Sjak-Shie, Robert A. Vescio, James R. Berenson

Research output: Contribution to journalArticlepeer-review

377 Scopus citations

Fingerprint

Dive into the research topics of 'The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents'. Together they form a unique fingerprint.

Medicine & Life Sciences